Targeting NRAS activator STK19 blocks melanocyte malignant transformation and melanoma growth Feb. 8, 2019
GF-1061 shows promising activity against Leishmania infantum and Leishmania amazonensis species Feb. 6, 2019
Immunosuppressive peptide R9-SOCS1-KIR prevents ocular damage in models of autoimmune uveitis Jan. 28, 2019
CX-23, an NQO1-selective activated prodrug of triptolide, shows promise in preclinical models of HCC Jan. 9, 2019